Stablecoin Development Corp (SDEV) Stock Price, Quote & News

Company Profile

Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was formerly known as NovaBay Pharmaceuticals, Inc. and changed its name to Stablecoi...

Industry: Asset Management

Sector: Financial Services

Phone: 510 899 8800

Fax: (510) 474-1577

Website: stabledev.com

Address:

2000 Powell Street, Suite 1150, Emeryville, United States

tcwine May. 22 at 11:50 PM

$SDEV Wow that’s huge news do you think they’ll put out a press release?

0 · Reply

Arthur86 May. 22 at 11:37 PM

$SDEV Loaded up for tuesday alongside $FEMY

0 · Reply

Tradebub May. 22 at 11:30 PM

$SDEV Filing for new 10% holder.

0 · Reply

tcwine May. 22 at 11:29 PM

$SDEV Wow that’s great where did you find a News can you share thank you

0 · Reply

Tradebub May. 22 at 11:28 PM

$SDEV Float is super compressed with all the large holders including the new 10% owner. Shorty will be gored on Tuesday. Don't forget that volume precedes price.

0 · Reply

Arthur86 May. 22 at 11:25 PM

$SDEV the richest man in Italy has bought a10% stake. Shame the news came out now and not during market open

0 · Reply

Hp23 May. 22 at 11:13 PM

$CHR better than $SDEV and $PHGE ...more so like $QTEX

1 · Reply

Hp23 May. 22 at 11:02 PM

$PHGE like $SDEV thus will go red too

0 · Reply

Arthur86 May. 22 at 11:01 PM

$SDEV wait till more eyes are on this over the weekend.

0 · Reply

Tradebub May. 22 at 10:51 PM

$SDEV Come on down - $PCLA and $AKTX. Next weeks big runner.

0 · Reply

Stablecoin Development Corporation Reports First Quarter 2026 Financial Results

May 20, 2026, 8:30 AM EDT - 2 days ago

Stablecoin Development Quarterly report: Q1 2026

May 20, 2026, 8:30 AM EDT - 2 days ago

Stablecoin Development Earnings release: Q1 2026

Apr 6, 2026, 8:30 AM EDT - 6 weeks ago

Stablecoin Development Corporation Begins Trading on NYSE American Under Ticker “SDEV”

Mar 23, 2026, 8:30 AM EDT - 2 months ago

NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update

Mar 19, 2026, 7:00 AM EDT - 2 months ago

Stablecoin Development Annual report: Q4 2025

Mar 12, 2026, 2:00 PM EDT - 2 months ago

Stablecoin Development Transcript: EGM 2026

Mar 2, 2026, 7:00 AM EST - 2 months ago

Stablecoin Development Proxy statement: Proxy Filing

Feb 10, 2026, 7:00 AM EST - 3 months ago

Stablecoin Development Proxy statement: Proxy Filing

Jan 30, 2026, 7:00 AM EST - 4 months ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 25, 2025, 7:00 AM EST - 6 months ago

Stablecoin Development Registration statement: Registration Filing

Nov 7, 2025, 4:00 PM EST - 7 months ago

Stablecoin Development Quarterly report: Q3 2025

Oct 20, 2025, 7:07 PM EDT - 7 months ago

NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards

Oct 9, 2025, 8:00 AM EDT - 8 months ago

Stablecoin Development Proxy statement: Proxy Filing

Oct 3, 2025, 8:00 AM EDT - 8 months ago

Stablecoin Development Registration statement: Registration Filing

Sep 23, 2025, 8:00 AM EDT - 8 months ago

Stablecoin Development Proxy statement: Proxy Filing

Sep 18, 2025, 4:30 PM EDT - 8 months ago

NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting

Sep 18, 2025, 8:00 AM EDT - 8 months ago

Stablecoin Development Proxy statement: Proxy Filing

Sep 10, 2025, 8:00 AM EDT - 9 months ago

Stablecoin Development Proxy statement: Proxy Filing

Aug 26, 2025, 4:05 PM EDT - 9 months ago

NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share

Aug 19, 2025, 5:25 PM EDT - 9 months ago

NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

Aug 14, 2025, 7:00 AM EDT - 10 months ago

Stablecoin Development Quarterly report: Q2 2025

May 14, 2025, 6:00 PM EDT - 1 year ago

Stablecoin Development Quarterly report: Q1 2025

Apr 2, 2025, 8:00 AM EDT - 1 year ago

Stablecoin Development Annual report: Q4 2024

Mar 19, 2025, 8:00 AM EDT - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Mar 7, 2025, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Mar 7, 2025, 6:50 AM EST - 1 year ago

NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders

Feb 18, 2025, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Feb 4, 2025, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Jan 23, 2025, 8:00 AM EST - 1 year ago

NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal

Jan 23, 2025, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Dec 19, 2024, 6:50 AM EST - 1 year ago

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders

Dec 18, 2024, 2:00 PM EST - 1 year ago

Stablecoin Development Transcript: EGM 2024

Dec 11, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Dec 9, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Dec 9, 2024, 6:50 AM EST - 1 year ago

NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting

Nov 26, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 22, 2024, 4:05 PM EST - 1 year ago

NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024

Nov 15, 2024, 8:00 AM EST - 1 year ago

Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand

Nov 15, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 13, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 12, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 12, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 7, 2024, 4:05 PM EST - 1 year ago

NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results

Nov 7, 2024, 4:00 PM EST - 1 year ago

Stablecoin Development Quarterly report: Q3 2024

Nov 6, 2024, 4:05 PM EST - 1 year ago

NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price

Nov 6, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Oct 29, 2024, 8:00 AM EDT - 1 year ago

NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC

Oct 29, 2024, 8:00 AM EDT - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Oct 16, 2024, 8:00 AM EDT - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Sep 25, 2024, 8:00 AM EDT - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Sep 20, 2024, 8:30 AM EDT - 1 year ago

Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals

Sep 20, 2024, 8:00 AM EDT - 1 year ago

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets

Sep 20, 2024, 8:00 AM EDT - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Aug 13, 2024, 4:30 PM EDT - 1 year ago

Stablecoin Development Earnings Call Transcript: Q2 2024

Aug 13, 2024, 4:30 PM EDT - 1 year ago

Stablecoin Development Quarterly report: Q2 2024

Aug 13, 2024, 4:05 PM EDT - 1 year ago

NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results

Aug 1, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024

Jul 30, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales

Jul 29, 2024, 4:05 PM EDT - 1 year ago

NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option

Jul 26, 2024, 8:30 AM EDT - 1 year ago

NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering

Jul 25, 2024, 8:00 AM EDT - 1 year ago

Stablecoin Development Registration statement: Registration Filing

Jul 16, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day

Jul 15, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Registration statement: Registration Filing

Jul 11, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million

Jul 10, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Registration statement: Registration Filing

Jul 1, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities

Jun 28, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions

Jun 21, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Registration statement: Registration Filing

Jun 20, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Registration statement: Registration Filing

Jun 7, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American

May 29, 2024, 5:22 PM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates

May 13, 2024, 8:30 AM EDT - 2 years ago

NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms

May 9, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Earnings Call Transcript: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Quarterly report: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Earnings release: Q1 2024

May 9, 2024, 4:05 PM EDT - 2 years ago

NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results

May 7, 2024, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon

May 3, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024

Apr 22, 2024, 6:57 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales

Apr 19, 2024, 6:00 PM EDT - 2 years ago

NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity

Apr 18, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Proxy statement: Proxy Filing

Apr 18, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Proxy statement: Proxy Filing

Apr 17, 2024, 6:59 AM EDT - 2 years ago

NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses

Apr 8, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Proxy statement: Proxy Filing

Mar 26, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Earnings Call Transcript: Q4 2023

Mar 26, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Earnings release: Q4 2023

Mar 26, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Annual report: Q4 2023

Mar 26, 2024, 4:05 PM EDT - 2 years ago

NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results

Mar 25, 2024, 6:38 PM EDT - 2 years ago

NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024

Mar 14, 2024, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023

Jan 30, 2024, 9:00 AM EST - 2 years ago

NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales

Jan 9, 2024, 9:15 AM EST - 2 years ago

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor Network

SNOA

Dec 6, 2023, 6:50 AM EST - 2 years ago

NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes

Nov 9, 2023, 4:30 PM EST - 2 years ago

Stablecoin Development Earnings Call Transcript: Q3 2023

Nov 9, 2023, 4:30 PM EST - 2 years ago

Stablecoin Development Quarterly report: Q3 2023

Nov 9, 2023, 4:05 PM EST - 2 years ago

NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results

Nov 2, 2023, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023

Oct 11, 2023, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs

Oct 2, 2023, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference

Sep 14, 2023, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Commercial Launch of Avenova® Allograft

Sep 11, 2023, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® Allograft

Aug 10, 2023, 4:30 PM EDT - 3 years ago

Stablecoin Development Earnings Call Transcript: Q2 2023

Aug 10, 2023, 4:30 PM EDT - 3 years ago

Stablecoin Development Quarterly report: Q2 2023

Aug 10, 2023, 4:05 PM EDT - 3 years ago

NovaBay Pharmaceuticals Reports Second Quarter 2023 Financial Results

tcwine May. 22 at 11:50 PM

$SDEV Wow that’s huge news do you think they’ll put out a press release?

0 · Reply

Arthur86 May. 22 at 11:37 PM

$SDEV Loaded up for tuesday alongside $FEMY

0 · Reply

Tradebub May. 22 at 11:30 PM

$SDEV Filing for new 10% holder.

0 · Reply

tcwine May. 22 at 11:29 PM

$SDEV Wow that’s great where did you find a News can you share thank you

0 · Reply

Tradebub May. 22 at 11:28 PM

$SDEV Float is super compressed with all the large holders including the new 10% owner. Shorty will be gored on Tuesday. Don't forget that volume precedes price.

0 · Reply

Arthur86 May. 22 at 11:25 PM

$SDEV the richest man in Italy has bought a10% stake. Shame the news came out now and not during market open

0 · Reply

Hp23 May. 22 at 11:13 PM

$CHR better than $SDEV and $PHGE ...more so like $QTEX

1 · Reply

Hp23 May. 22 at 11:02 PM

$PHGE like $SDEV thus will go red too

0 · Reply

Arthur86 May. 22 at 11:01 PM

$SDEV wait till more eyes are on this over the weekend.

0 · Reply

Tradebub May. 22 at 10:51 PM

$SDEV Come on down - $PCLA and $AKTX. Next weeks big runner.

0 · Reply

DaSqueeza May. 22 at 10:49 PM

$SDEV 3 cents down and the roundtrip is complete. would love to add between 1-1.20 on tuesday

0 · Reply

tcwine May. 22 at 10:49 PM

$SDEV Major Holders Breakdown 88.51% % of Shares Held by All Insider 6.80% % of Shares Held by Institutions 59.16% % of Float Held by Institutions 27 Number of Institutions Holding Shares

0 · Reply

Tradebub May. 22 at 10:48 PM

$SDEV https://www.sec.gov/Archives/edgar/data/1389545/000119312526237063/xslSCHEDULE_13G_X02/primary_doc.xml

0 · Reply

islandpunk May. 22 at 10:41 PM

$SDEV Institutional buyers think differently https://fintel.io/so/us/sdev

0 · Reply

islandpunk May. 22 at 10:40 PM

$SDEV Little bitch blocked me for sharing correct information. Go fuck yourself short motherfuckers.

0 · Reply

Ron_Burn May. 22 at 10:38 PM

$SDEV i just blocked you, punk

0 · Reply

Hp23 May. 22 at 10:36 PM

$SDEV still junk though bas3d on price action... ZERO support

0 · Reply

islandpunk May. 22 at 10:35 PM

$SDEV that's the old ticker info. It used to be a pharmaceutical company called NovaBay. It's clearly not updated.

0 · Reply

Hp23 May. 22 at 10:34 PM

$SDEV falling

0 · Reply

Hp23 May. 22 at 10:32 PM

$SDEV trash it

0 · Reply

Ron_Burn May. 22 at 10:30 PM

$SDEV not only the chart, everything about this trash is sus

1 · Reply

Hp23 May. 22 at 10:29 PM

$SDEV will close red

0 · Reply

Market Cap	41.22M
Revenue (ttm)	0.00
Net Income (ttm)	-22.14M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	5,150,653
Avg Vol	325,952
Day's Range	N/A - N/A
Shares Out	27.12M
Stochastic %K	11%
Beta	0.16
Analysts	Strong Buy
Price Target	N/A